Long-term effects of LCPUFA supplementation on childhood cognitive outcomes

American Journal of Clinical Nutrition

Volumn 98, Issue 2, 2013, Pages 403-412

  Colombo, John ^a   Carlson, Susan E ^b   Cheatham, Carol L ^b   Shaddy, D Jill ^b   Kerling, Elizabeth H ^b   Thodosoff, Jocelynn M ^b   Gustafson, Kathleen M ^b   Brez, Caitlin ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; LONG CHAIN POLYUNSATURATED FATTY ACID; PLACEBO; POLYUNSATURATED FATTY ACID; UNCLASSIFIED DRUG;

ARTICLE; BAYLEY SCALES OF INFANT DEVELOPMENT; CHILD; CHILDHOOD; COGNITION; COGNITIVE DEVELOPMENT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; INFANT; INHIBITION (PSYCHOLOGY); LANGUAGE; LEARNING; MACARTHUR BATES COMMUNICATIVE DEVELOPMENT INVENTORY; MAJOR CLINICAL STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PEABODY PICTURE VOCABULARY TEST; PRESCHOOL CHILD; PROBLEM SOLVING; RANDOMIZED CONTROLLED TRIAL; SPATIAL MEMORY; STROOP TEST; SUPPLEMENTATION; TASK PERFORMANCE; WESCHLER PRIMARY PRESCHOOL SCALES OF INTELLIGENCE;

CHILD, PRESCHOOL; COGNITION; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; EXECUTIVE FUNCTION; FATTY ACIDS, UNSATURATED; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; INTELLIGENCE; LONGITUDINAL STUDIES; MALE; MEMORY; PROBLEM SOLVING;

EID: 84881235994     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.112.040766     Document Type: Article

References (40)

1. Makrides M, Neumann MA, Byard RW, Simmer K, Gibson RA. Fattyacid composition of brain, retina, and erythrocytes in breast-fed and formula-fed infants. Am J Clin Nutr 1994;60:189-94.
2. Green P, Yavin E. Fatty acid composition of late embryonic and early postnatal rat brain. Lipids 1996;31:859-65.
3. Yavin E, Glozman S, Green P. Docosahexaenoic acid accumulation in the prenatal brain-prooxidant and antioxidant features. J Mol Neurosci 2001;16:229-35.
4. Cheatham CL, Colombo J, Carlson SE. n23 fatty acids and cognitive and visual acuity development: methodologic and conceptual considerations. Am J Clin Nutr 2006;83:1458S-66S.
5. Willatts P, Forsyth JS. The role of long-chain polyunsaturated fatty acids in infant cognitive development. Prostaglandins Leukot Essent Fatty Acids 2000;63:95-100.
6. Luzon-Toro B, Schaefer S, Wirths O, Jimenez-Lopez J, Boza-Puerta J, Geerlings A, Falkai P, Bayer TA. Dietary fatty acids and brain mechanism of action throughout the lifespan. Neurol Psychiatry Brain Res 2004;11:149-60.
7. Wainwright P. Effect of nutritional manipulation on brain function: implications for future research. Am J Clin Nutr 2006;83:919-21.
8. Reisbick S, Neuringer M, Gohl E, Wald R, Anderson GJ. Visual attention in infant monkeys: effects of dietary fatty acids and age. Dev Psychol 1997;33:387-95.
9. Drover J, Hoffman DR, Castañeda YS, Morale SE, Birch EE. Three randomized controlled trials of early long-chain polyunsaturated fatty acid supplementation on means-end problem solving in nine montholds. Child Dev 2009;80:1376-84.
10. Colombo J, Carlson SE, Cheatham CL, Fitzgerald-Gustafson KM, Kepler A, Doty T. Long-chain polyunsaturated fatty acid supplementation in infancy reduces heart rate and positively affects distribution of attention. Pediatr Res 2011;70:406-10.
11. Werkman SH, Carlson SE. A randomized trial of visual attention in preterm infants fed docosahexaenoic acid until nine months. Lipids 1996;31:91-7.
12. Isaacs EB, Ross S, Kennedy K, Weaver LT, Lucas A, Fewtrell MS. 10-Year cognition in preterms after random assignment to fatty acid supplementation in infancy. Pediatrics 2011;128:e890-8.
13. Birch EE, Garfield S, Castaneda Y, Hughbanks-Wheaton D, Uauy R, Hoffman D. Visual acuity and cognitive outcomes at 4 years of age in a double-blind, randomized trial of long-chain polyunsaturated fatty acid-supplemented infant formula. Early Hum Dev 2007;83:279-84.
14. Birch EE, Garfield S, Hoffman DR, Uauy R, Birch DG. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev Med Child Neurol 2000;42:174-81.
15. Drover JR, Hoffman DR, Castaneda YS, Morale SE, Garfield S, Wheaton DH, Birch EE. Cognitive function in 18-month-old term infants of the DIAMOND study: a randomized, controlled clinical trial with multiple dietary levels of docosahexaenoic acid. Early Hum Dev 2011;87:223-30.
16. Beyerlein A, Hadders-Algra M, Kennedy K, Fewtrell M, Singhal A, Rosenfeld E, Lucas A, Bouwstra H, Koletzko B, VonKries R. Infant formula supplementation with long-chain polyunsaturated fatty acids has no effect on Bayley developmental scores at 18 months of age- IPD meta-analysis of four large clinical trials. J Pediatr Gastroenterol Nutr 2010;50:79-84.
17. Smithers LG, Gibson RA, McPhee A, Makrides M. Effect of longchain polyunsaturated fatty acid supplementation of preterm infants on disease risk and neurodevelopment: a systematic review of randomized controlled trials. Am J Clin Nutr 2008;87:912-20.
18. Simmer K, Patole SK, Rao SC. Long-chain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst Rev 2008;CD000376.
19. Hadders-Algra M, Bouwstra H, van Goor SA, Dijck-Brouwer DA, Muskiet FA. Prenatal and early postnatal fatty acid status and neurodevelopmental outcome. J Perinat Med 2007;35(suppl 1):S28-34.
20. Simmer K, Patole SK, Rao SC. Long-chain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst Rev 2011;Dec 7:CD000376.
21. Schulzke SM, Patole SK, Simmer K. Long-chain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Database Syst Rev 2011;Feb 16:CD000375.
22. Qawasmi A, Landeros-Weisenberger A, Leckman JF, Bloch MH. Meta-analysis of long-chain polyunsaturated fatty acid supplementation of formula and infant cognition. Pediatrics 2012;129:1141-9.
23. Makrides M, Gibson RA, McPhee AJ, Collins CT, Davis PG, Doyle LW, Simmer K, Colditz PB, Morris S, Smithers LG, et al. Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial. JAMA 2009;301:175-82.
24. Colombo J. Recent advances in infant cognition: implications for longchain polyunsaturated fatty acid supplementation studies. Lipids 2001; 36:919-26.
25. Wainwright PE, Colombo J. Nutrition and the development of cognitive functions: interpretation of behavioral studies in animals and human infants. Am J Clin Nutr 2006;84:961-70.
26. Birch EE, Carlson SE, Hoffman DR, Fitzgerald-Gustafson KM, Fu VL, Drover JR, Castaneda YS, Minns L, Wheaton DK, Mundy D, et al. The DIAMOND (DHA Intake And Measurement Of Neural Development) Study: a double-masked, randomized controlled clinical trial of the maturation of infant visual acuity as a function of the dietary level of docosahexaenoic acid. Am J Clin Nutr 2010;91: 848-59.
27. Colombo J, Shaddy DJ, Richman WA, Maikranz JM, Blaga OM. The developmental course of habituation in infancy and preschool outcome. Infancy 2004;5:1-38.
28. Bayley N. Bayley Scales of Infant Development. 2nd ed. San Antonio, TX: The Psychological Corporation, 1970.
29. Fenson L, Dale PS, Reznick JS, Bates E, Thal DJ, Pethick SJ. Variability in early communicative development. Monogr Soc Res Child Dev 1994;59:1-173.
30. Schutte AR, Spencer JP, Schoner G. Testing the dynamic field theory: working memory for locations becomes more spatially precise over development. Child Dev 2003;74:1393-417.
31. Carlson SM, Moses LJ, Claxton LJ. Individual differences in executive functioning and theory of mind: an investigation of inhibitory control and planning ability. J Exp Child Psychol 2004;87:299-319.
32. Carlson SM, Moses LJ. Individual differences in inhibitory control and children's theory of mind. Child Dev 2001;72:1032-53.
33. Gerstadt CL, Hong YJ, Diamond A. The relationship between cognition and action: performance of children 3.5-7 years old on a Strooplike day-night test. Cognition 1994;53:129-53.
34. Zelazo PD. The Dimensional Change Card Sort (DCCS): a method of assessing executive function in children. Nat Protoc 2006;1:297-301.
35. Welsh MC, Pennington BF, Groisser DB. A normative developmental study of executive function: a window on prefrontal function in children. Dev Neuropsychol 1991;7:131-49.
36. Dunn LM, Dunn DN. Peabody Picture Vocabulary Test. 4th ed. San Antonio, TX: Pearson/PsyCorp, 2007.
37. Weschler D. Weschler Primary Preschool Scales of Intelligence-III. Upper Saddle River, NJ: Pearson, 2002.
38. Clandinin MT, Van Aerde JE, Merkel KL, Harris CL, Springer MA, Hansen JW, Diersen-Schade DA. Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid. J Pediatr 2005;146:461-8.
39. Colombo J. Infant cognition: predicting later intellectual functioning. Newbury Park, CA: Sage Publications Inc, 1993.
40. Jensen CL, Voigt RG, Llorente AM, Peters SU, Prager TC, Zou YLL, Rozelle JC, Turcich MR, Fraley JK, Anderson RE, et al. Effects of early maternal docosahexaenoic acid intake on neuropsychological status and visual acuity at five years of age of breast-fed term infants. J Pediatr 2010;157:900-5.